Rickettsia monoclonal antibody

ViroStat has released a new monoclonal antibody to the rickettsiae LPS. It is reactive with all members of the spotted fever group of rickettsiae. It does not cross react with the typhus group (R. typhi or R. prowazekii). This new antibody functions in enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA) and may also function in other rapid test formats.

Rickettsia rickettsii is an obligate intracellular Gram-negative bacterium that can infect humans and other invertebrates. The most common human disease is spotted fever. Transmission occurs from the bite of various infected arthropods, the most common being the American dog tick and the Rocky Mountain wood tick. Typical symptoms are fever, headache and a rash. Prompt treatment with doxycycline is recommended.

www.virostat-inc.com

 

Other news

Learning from history

Upcoming Events

Lab Innovations

NEC, Birmingham (Hall 12)
30-31 October 2019

British Society for Immunology Congress

Arena and Convention Centre, Kings Dock, Liverpool Waterfront, Liverpool L3 4FP
2-5 December 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Oct 2019

Are you ready for the winter influenza season?

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.